Tag: Zoll

LifeVest Wearable Defibrillator Reduces Total Mortality By 36 Percent At 90 Days

CHELMSFORD, Mass., March 10, 2018 /PRNewswire/ — ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today the results from the “Vest Prevention of Early Sudden Death Trial (VEST).” The study demonstrated that use of the LifeVest® wearable cardioverter […]

Results of Landmark Wearable Defibrillator Trial to Be Presented as ACC.18 Late-Breaker

CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today that findings from the “Vest Prevention of Early Sudden Death Trial” (VEST Trial) on use of the ZOLL LifeVest® wearable cardioverter defibrillator (WCD) will […]